Oruka Therapeutics, Inc. ORKA Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s investment proceeds?
- Oruka Therapeutics, Inc. (ORKA) reported investment proceeds of $76.47M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Oruka Therapeutics, Inc.'s investment proceeds decreased by 12.3% year-over-year, from $87.17M to $76.47M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.